Vlado Perkovic

Research interests

Publications

• Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02074-8

• Chronic kidney disease

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00519-5

• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00590-0

• Effects of Allopurinol on the Progression of Chronic Kidney Disease

  New England Journal of Medicine · 2020 · 10.1056/nejmoa1915833

• SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

  The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30256-6

• Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1811744

• Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

  American Journal of Kidney Diseases · 2019 · 10.1053/j.ajkd.2019.06.009

• Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30772-x

• Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

  JAMA · 2018 · https://doi.org/10.1001/jama.2018.18269

• Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

  The Lancet Diabetes & Endocrinology · 2018 · 10.1016/s2213-8587(18)30141-4

• Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

  Circulation · 2018 · 10.1161/circulationaha.118.034222

• Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1611925

• Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

  JAMA · 2017 · 10.1001/jama.2017.9362

• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

  The Lancet · 2017 · 10.1016/s0140-6736(17)30788-2

• Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events

  Circulation · 2017 · 10.1161/circulationaha.117.032038

• A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension

  The Lancet · 2016 · 10.1016/s0140-6736(16)31134-5

• Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

  The Lancet · 2015 · 10.1016/s0140-6736(15)00805-3

• Blood Pressure Lowering in Type 2 Diabetes

  JAMA · 2015 · 10.1001/jama.2014.18574

• Worldwide access to treatment for end-stage kidney disease: a systematic review

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(14)61601-9

• Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

  American Journal of Kidney Diseases · 2015 · 10.1053/j.ajkd.2015.10.011

• Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

  New England Journal of Medicine · 2014 · 10.1056/nejmoa1407963

• Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

  PLoS Medicine · 2012 · 10.1371/journal.pmed.1001293

• Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

  The Lancet · 2010 · 10.1016/s0140-6736(10)60656-3

• Is Low Birth Weight an Antecedent of CKD in Later Life? A Systematic Review of Observational Studies

  American Journal of Kidney Diseases · 2009 · 10.1053/j.ajkd.2008.12.042

• Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

  Journal of the American Society of Nephrology · 2009 · 10.1681/asn.2008121270

Current projects

No projects listed.